ECG Telemetry Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

ECG Telemetry Devices Market is segmented By Product (Event Monitoring and MCT (Mobile Cardiac Telemetry), Others), By Application (Arrhythmias, Myocardial Ischemia, and Infarction, Pacemaker Monitoring, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

ECG Telemetry Devices Market Overview

Report on Global ECG Telemetry Devices Market by DataM Intelligence estimates the market to grow at a CAGR of 8% during the forecast period 2024-2031. ECG Telemetry Devices usage in diagnosing cardiac abnormalities is on the rise. Demand from Hospitals and Diagnostic Centers in North America is booming. Competitive rivalry intensifies with BioTelemetry Inc, iRhythm Technologies Inc, Medicalgorithmics SA and others operating in the market.

ECG device monitors and records the electrical movement of the heart. It detects and gathers electrical impulses generated by the polarization and depolarization of cardiac tissue and translates them into a waveform. It helps physicians or cardiologists diagnose cardiac abnormalities and the size and position of chambers. This technique detects cardiac abnormalities and analyzes the effects of drugs or devices used to regulate the heart. The ECG telemetry device can detect complex dysrhythmias and myocardial ischemia. The ECG telemetry devices market is driving due to the growing government interventions to reform the healthcare sector. Moreover, technological advances and increasing government interventions to render quality medical devices at affordable prices for miniature and telemetry devices have grown significantly in the past couple of years.

As per DataM Intelligence, ECG Telemetry Devices Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global ECG Telemetry Devices Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. ECG Telemetry Devices Market in the United States and Canada produces the utmost share. Whereas the European ECG Telemetry Devices Market is projected to continue its presence globally during the period of 2024-2031.

ECG Telemetry Devices Market Scope

To Get a Free Sample Click here

ECG Telemetry Devices Market Trends

Home monitoring devices lead the market’s growth.

Homecare monitoring devices' demand increases, reducing the cost and time taken in hospitals for heart checkups. For life-threatening diseases, such as cardiovascular disorders, regular checkup of the heart is crucial, and it is made easy by homecare monitoring devices. Hence, these devices are helping the ECG telemetry devices market to grow.

Also, the Increasing incidence and prevalence of cardiovascular diseases drive market growth. Over the past two decades, fatalities due to cardiovascular disease and other heart diseases have been declining in high-income countries; however, they have been rising at an alarming rate in lower and middle-income countries. Around 80.0% of the mortalities caused due to CVD occur in low-middle income group regions, such as Africa, Latin America, and Asia-Pacific, as per the WHO. In North America, myocardial infarction fatality is continuously decreasing due to several factors, such as drug-eluting stents, increasing adoption of percutaneous coronary angioplasty, and evidence-based medications for primary and secondary prevention of major adverse cardiovascular diseases.

ECG Telemetry Devices Market Segmentation Analysis

Event monitoring and MCT (Mobile Cardiac Telemetry) segment accounted for the highest share in global ECG telemetry devices market.

The event monitoring and MCT (Mobile Cardiac Telemetry) segment are anticipated to dominate the market with the largest value share. Mobile cardiac telemetry is the most modern of the monitoring options. MCT devices are small portable monitors that automatically send data when a cardiac anomaly is detected. It is superior to other forms of ambulatory cardiac monitoring (Holter or Event Monitoring); therefore, its demand is expected to rise in the ECG telemetry device market during the forecast period.

By application, the ECG telemetry devices market is classified into arrhythmia, myocardial ischemia and infarction, pacemaker monitoring, and others. In terms of application, the arrhythmia segment is expected to dominate the global ECG telemetry devices market during the forecast period. In arrhythmia, the heart rhythm functions abnormally, wherein the electrical impulses either occur too fast or too slow, leading to the reduced proficiency of the heart to pump blood. There are various devices used in arrhythmias diagnosis. The ECG telemetry devices are one of the most efficient tools to detect arrhythmias. According to World Health Organization estimation data, the aged population above 60 years and over increased in 2020. By 2050, the aged population above 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. As this population is more prone to cardiovascular diseases such as arrhythmias, the demand for ECG telemetry devices to diagnose arrhythmia is expected to impact the market positively.

Global ECG Telemetry Devices Market Geographical Share

North America is the dominating region during the forecast period.

During the forecast period, the North American market leads with the largest share in the global ECG telemetry devices market. Cardiovascular diseases are the primary cause of mortality in the U.S. and the major cause of acute hospital bed days and physician visits. According to the Centers for Disease Control and Prevention (CDC), about 610,000 mortalities are registered due to cardiovascular diseases in the U.S. every year, which accounts for almost one in every four fatalities. Therefore, the demand for ECG telemetry devices is considerably accurately high in the U.S., which drives the market growth in the region, especially in the U.S.

Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally during the forecast period. This growth is due to the increased government initiatives on hospitals, computerization, and infrastructure. The existing healthcare infrastructure in the Asia-Pacific countries such as India, China, Japan, and Australia is still in progress. Significant prospects exist for developing novel ECG telemetric devices in developing regions. Approximately half of the burden of the world of CVD is carried by the Asia-Pacific region. Therefore, the large patient population indicates an imminent need for the ECG telemetry device market.

ECG Telemetry Devices Market Companies and Competitive Landscape

The ECG telemetry devices market is dominated by a few companies. Key players in the market's growth include Aerotel Medical Systems Ltd., BioTelemetry Inc., GE Healthcare, Medtronic Plc, iRhythm Technologies Inc., Nihon Kohden Corporation, Philips Healthcare, and Medicalgorithmics SA, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global ECG telemetry devices market. In March 2022, GE Healthcare announced a partnership with AliveCor to launch a new digital platform at HIMSS. The company made two major announcements at the Orlando Global Health Conference & Exhibition. The company's first announcement is the development of an AI-enabled digital health platform. And another announcement is about a partnership with Mountain View, California-based AliveCor, through which electrocardiogram readings taken on the medical device company's EKG device will be delivered directly into GE Healthcare's MUSE Cardiac Management System. In April 2022, GE Healthcare and Medtronic Announced a Collaboration to Meet the Growing Need for Outpatient Care. Under this collaboration, customers accessed extensive product portfolios, financial solutions, and exceptional service.

COVID-19 Impact on ECG Telemetry Devices Market

Negative impact on the global ECG Telemetry Devices market.

The companies operating in the global ECG telemetry devices market have a good prospect at their disposal as the COVID-19 pandemic grips several parts worldwide. These vendors are expected to accelerate their manufacturing pace to meet the expanding demand for ECG telemetry devices. Investments in novel technologies used to monitor COVID-19 have increased in recent times. It has offered a large playfield of advancement for the companies operating in the global ECG telemetry devices market. Furthermore, the ECG telemetry devices market's leading players focus on developing custom-made devices to monitor the fundamentals of COVID-19 patients.